Allergan Files SBLA To Extend Use Of BOTOX For Patients 5 To 17 Years Old

(RTTNews) – Allergan, an AbbVie (ABBV) company, announced the U.S. FDA has accepted the company’s supplemental biologics license application to expand the BOTOX prescribing information for the …
( read original story …)


Advertisement